Pioglitazone improves the ability of learning and memory via activating ERK1/2 signaling pathway in the hippocampus of T2DM rats

This publication has 31 references indexed in Scilit:

• Diabetes and risk of physical disability in adults: a systematic review and meta-analysis
  The Lancet Diabetes & Endocrinology, 2013
• Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
  Journal of Diabetes Investigation, 2012
• Diabetes, hyperglycemia and the management of cerebrovascular disease
  Current Opinion in Neurology, 2011
• Cognitive Function in Type 1 Diabetic Adults With Early Exposure to Severe Hypoglycemia
  Diabetes Care, 2010
• Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
  Journal of Alzheimer’s Disease, 2010
• Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
  Diabetes, Metabolic Syndrome and Obesity, 2010
• ERK in Learning and Memory: A Review of Recent Research
  International Journal of Molecular Sciences, 2010
• Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance
  Diabetes, 2006
• Peroxisome Proliferator-Activated Receptor γ Down-Regulates Receptor for Advanced Glycation End Products and Inhibits Smooth Muscle Cell Proliferation in a Diabetic and Nondiabetic Rat Carotid Artery Injury Model
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Systemic insulin‐like growth factor‐I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats
  Journal of Neuroscience Research, 2003